| Dr William P Walker, MD | |
|
601 John St, Kalamazoo, MI 49007-5341 | |
| (269) 341-7654 | |
| Not Available |
| Full Name | Dr William P Walker |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 601 John St, Kalamazoo, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346223088 | NPI | - | NPPES |
| 3286402 | Medicaid | MI | |
| 3286449 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 4301067361 (Michigan) | Primary |
| Entity Name | Patholgy Services Of Kalamazoo Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548243595 PECOS PAC ID: 0143123034 Enrollment ID: O20040128001118 |
News Archive
The report of an independent review of social and ethical challenges associated with research into, and the application of, synthetic biology, is published (9 June).
The Economist on Friday published two articles from Saturday's print edition regarding the XIX International AIDS Conference (AIDS 2012). One article states that "few areas of international affairs have seen more recent success than the fight against AIDS," and discusses advancements in HIV treatment research and availability.
Researchers at the University of Pennsylvania School of Medicine recently identified how a regulatory protein called Bcl-3 helps to control the body's inflammation response to infection by interfering a critical biochemical process called ubiquitination.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
Two independent teams of researchers have identified a role for enhanced activation of the signaling protein Notch in tumors characterized by inactivation of either the TSC1 or the TSC2 protein. As indicated by Warren Pear, at the University of Pennsylvania, Philadelphia, in an accompanying commentary, these data provide a rationale for testing whether Notch inhibitors are of benefit to those with TSC-associated tumors.
› Verified 7 days ago
| Entity Name | Diagnostic Pathology Services Of Southwest Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912241597 PECOS PAC ID: 1456598473 Enrollment ID: O20130513000074 |
News Archive
The report of an independent review of social and ethical challenges associated with research into, and the application of, synthetic biology, is published (9 June).
The Economist on Friday published two articles from Saturday's print edition regarding the XIX International AIDS Conference (AIDS 2012). One article states that "few areas of international affairs have seen more recent success than the fight against AIDS," and discusses advancements in HIV treatment research and availability.
Researchers at the University of Pennsylvania School of Medicine recently identified how a regulatory protein called Bcl-3 helps to control the body's inflammation response to infection by interfering a critical biochemical process called ubiquitination.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
Two independent teams of researchers have identified a role for enhanced activation of the signaling protein Notch in tumors characterized by inactivation of either the TSC1 or the TSC2 protein. As indicated by Warren Pear, at the University of Pennsylvania, Philadelphia, in an accompanying commentary, these data provide a rationale for testing whether Notch inhibitors are of benefit to those with TSC-associated tumors.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William P Walker, MD 5700 Southwyck Blvd, Toledo, OH 43614-1509 Ph: (800) 288-8325 | Dr William P Walker, MD 601 John St, Kalamazoo, MI 49007-5341 Ph: (269) 341-7654 |
News Archive
The report of an independent review of social and ethical challenges associated with research into, and the application of, synthetic biology, is published (9 June).
The Economist on Friday published two articles from Saturday's print edition regarding the XIX International AIDS Conference (AIDS 2012). One article states that "few areas of international affairs have seen more recent success than the fight against AIDS," and discusses advancements in HIV treatment research and availability.
Researchers at the University of Pennsylvania School of Medicine recently identified how a regulatory protein called Bcl-3 helps to control the body's inflammation response to infection by interfering a critical biochemical process called ubiquitination.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
Two independent teams of researchers have identified a role for enhanced activation of the signaling protein Notch in tumors characterized by inactivation of either the TSC1 or the TSC2 protein. As indicated by Warren Pear, at the University of Pennsylvania, Philadelphia, in an accompanying commentary, these data provide a rationale for testing whether Notch inhibitors are of benefit to those with TSC-associated tumors.
› Verified 7 days ago
Dr. Albert D Mason, MD Pathology Medicare: Medicare Enrolled Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
Dr. Kevin M. Herzog, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
Dr. Nigel H. Bramwell, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
Dr. William T Leeburg, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
William J Walter, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1521 Gull Rd, Kalamazoo, MI 49048 Phone: 269-226-7000 | |
Steven P Soper, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1521 Gull Rd, Kalamazoo, MI 49048 Phone: 269-226-7000 |